Czech National Bank Grows Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Czech National Bank boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 211,375 shares of the healthcare conglomerate's stock after purchasing an additional 11,839 shares during the quarter. UnitedHealth Group comprises 1.0% of Czech National Bank's holdings, making the stock its 15th largest holding. Czech National Bank's holdings in UnitedHealth Group were worth $110,708,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group in the fourth quarter worth about $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group in the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at approximately $32,000. Institutional investors own 87.86% of the company's stock.

Insider Activity

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the purchase, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the company's stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock worth $31,607,768 over the last three months. Insiders own 0.33% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Morgan Stanley cut their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Mizuho dropped their target price on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Raymond James lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Finally, Truist Financial reiterated a "buy" rating and issued a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $428.43.

UnitedHealth Group Price Performance

UNH traded down $3.29 during midday trading on Tuesday, hitting $301.43. 12,704,993 shares of the company traded hands, compared to its average volume of 6,860,993. The company has a market capitalization of $273.44 billion, a price-to-earnings ratio of 19.45, a PEG ratio of 1.37 and a beta of 0.56. The business has a 50 day simple moving average of $426.60 and a two-hundred day simple moving average of $490.74. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter last year, the business earned $6.91 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.